James Hartley (2026) “Aberrant Splicing Factor SF3A2 as a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay with Immune Infiltration and Natural Product Intervention”, International Journal of Medical Science and Dental Health, 12(09), pp. 176–181. doi:10.55640/ijmsdh-12-09-20.